Form Filed By Angermayer Christian
Fri, Feb 14, 2025
Go to original document
ATAI Life Sciences N.V. (ATAI)
Healthcare
Biotechnology
Insights
Coming soon
Non Derivative Transactions
2025-02-14
Common Shares
Purchase
P
Type
Acquired 10,835,718 shares @ $2.10 per share
40,555,216 shares
By Apeiron Investment Group Ltd.
Indirect
Common Shares
Other
Type
Disposed 0 shares @ $0.00 per share
1,799,302 shares
By Apeiron Presight Capital Fund II, L.P.
Indirect